Half year 2020 results

Transformational performance set to continue Paris, France and Camberley, UK – 17 September 2020 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the six months ended 30 June 2020 and provides an update on its growth strategy. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-Interim-Results-to-June-2020-17.09.20-ENGLISH.pdf

Visit Page

Appointment of Joint Broker

Paris, France and Camberley, UK – 16 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of Numis Securities Limited as Joint Broker to the Company with immediate effect. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-Appointment-of-Joint-Broker.pdf

Visit Page

Nomination d’un Joint Broker

Paris, France et Camberley, Royaume-Uni – 16 septembre 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, a le plaisir d’annoncer la nomination de Numis Securities Limited en tant que Joint Broker du Groupe avec effet immédiat. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-Nomination-dun-Joint-Broker.pdf

Visit Page